ERVOGASTAT

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C21H21N5O4
Molecular Weight	407.4225
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of ERVOGASTAT

Structure Search

SMILES

CCOC1=CC=CN=C1OC2=CN=CC(=C2)C3=NC=C(C=N3)C(=O)N[C@H]4CCOC4

InChI

InChIKey=UKBQFBRPXKGJPY-INIZCTEOSA-N

InChI=1S/C21H21N5O4/c1-2-29-18-4-3-6-23-21(18)30-17-8-14(9-22-12-17)19-24-10-15(11-25-19)20(27)26-16-5-7-28-13-16/h3-4,6,8-12,16H,2,5,7,13H2,1H3,(H,26,27)/t16-/m0/s1

HIDE SMILES / InChI

Molecular Formula	C21H21N5O4
Molecular Weight	407.4225
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	1 / 1
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Sat Dec 16 13:19:00 GMT 2023` Edited by `admin` on `Sat Dec 16 13:19:00 GMT 2023`
Record UNII	BSOIY5AKQW
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

ERVOGASTAT

Official Name

English

5-PYRIMIDINECARBOXAMIDE, 2-(5-((3-ETHOXY-2-PYRIDINYL)OXY)-3-PYRIDINYL)-N-((3S)-TETRAHYDRO-3-FURANYL)-

Systematic Name

English

ervogastat [INN]

Common Name

English

2-(5-((3-ETHOXYPYRIDIN-2-YL)OXY)PYRIDIN-3-YL)-N-((3S)-OXOLAN3-YL)PYRIMIDINE-5-CARBOXAMIDE

Systematic Name

English

Code System Code Type Description

FDA UNII

BSOIY5AKQW

Created by admin on Sat Dec 16 13:19:01 GMT 2023 , Edited by admin on Sat Dec 16 13:19:01 GMT 2023

PRIMARY

INN

11616

Created by admin on Sat Dec 16 13:19:01 GMT 2023 , Edited by admin on Sat Dec 16 13:19:01 GMT 2023

PRIMARY

INN

NCI_THESAURUS

C179085

Created by admin on Sat Dec 16 13:19:01 GMT 2023 , Edited by admin on Sat Dec 16 13:19:01 GMT 2023

PRIMARY

PUBCHEM

134262752

Created by admin on Sat Dec 16 13:19:01 GMT 2023 , Edited by admin on Sat Dec 16 13:19:01 GMT 2023

PRIMARY

SMS_ID

300000018071

Created by admin on Sat Dec 16 13:19:01 GMT 2023 , Edited by admin on Sat Dec 16 13:19:01 GMT 2023

PRIMARY

CAS

2186700-33-2

Created by admin on Sat Dec 16 13:19:01 GMT 2023 , Edited by admin on Sat Dec 16 13:19:01 GMT 2023

PRIMARY

Related Record Type Details


					UTV23GAR8C

DIACYLGLYCEROL O-ACYLTRANSFERASE 2

TARGET -> INHIBITOR

Interaction Type:

INHIBITOR

Qualification:

IC50

Amount:


					22ES734693

MULTIDRUG RESISTANCE PROTEIN 1

TRANSPORTER -> INHIBITOR

Qualification:

IC50

Amount:


					SEV29N8JND

POTASSIUM VOLTAGE-GATED CHANNEL SUBFAMILY H MEMBER 2

TRANSPORTER -> NON-INHIBITOR

Qualification:

IC50

Amount:


					L9DP834D1P

CYTOCHROME P450 2C9

METABOLIC ENZYME -> INHIBITOR

Qualification:

IC50

Amount:


					6NP3XSMIP3

MULTIDRUG AND TOXIN EXTRUSION PROTEIN 1

TRANSPORTER -> INHIBITOR

Qualification:

IC50

Amount:


					SEV29N8JND

POTASSIUM VOLTAGE-GATED CHANNEL SUBFAMILY H MEMBER 2

OFF TARGET->NON-INHIBITOR

Amount:


					76UB6O122H

ATP-BINDING CASSETTE SUB-FAMILY G MEMBER 2

TRANSPORTER -> INHIBITOR

Qualification:

IC50

Amount:

Related Record Type Details


					EP3565J83G

2-[5-[(3-Ethoxypyridin-2-yl)oxy]pyridin-3-yl]pyrimidine-5-carboxylic acid

METABOLITE -> PARENT

Amount:


					322B8YY2MA

(S)-3-(2-(5-((3-ethoxypyridin-2-yl)oxy)pyridin-3-yl)pyrimidine-5-carboxamido)-4-hydroxybutanoic acid

METABOLITE -> PARENT

Amount:


					322B8YY2MA

(S)-3-(2-(5-((3-ethoxypyridin-2-yl)oxy)pyridin-3-yl)pyrimidine-5-carboxamido)-4-hydroxybutanoic acid

METABOLITE -> PARENT

Comments:

From hepatocyte

Amount:


					GB2PA62UHB

Ervogastat metabolite M3

METABOLITE -> PARENT

Amount:


					QU9LFW2LKW

Ervogastat metabolite M2

METABOLITE -> PARENT

Amount:


					7AQT3Z7LD7

Ervogastat metabolite M1

METABOLITE -> PARENT

Amount:

Related Record Type Details


					BSOIY5AKQW

ACTIVE MOIETY

Amount: